Non-Ovlon

inhibits ovulation; contains above two cpds

Networked: 13 relevant articles (1 outcomes, 2 trials/studies)

1.	Acne Vulgaris 12/01/1970 - "[Efficacy of Non-ovlon in female patients with acne vulgaris]."
2.	Carcinogenesis 01/01/1988 - "The objective of this study was to give a contribution to the question whether there are changes in the uterine cervix after longterm application of 19-norsteroid-containing contraceptives Non-Ovlon and Gravistat relating to carcinogenesis. "
3.	Hyperlipidemias (Hyperlipidemia) 08/01/1985 - " Results indicate that none of the OCs under study (Non-ovlon, Ovidan, Rigevidon, and Triquilar) induces pathological hyperlipidemia. "
4.	Neoplasms (Cancer) 02/15/1981 - "[Liver tumor after long-term administration of NON OVLON]." 01/01/1988 - "Our investigations revealed no morphological evidence for a relation between longterm application of Non-Ovlon or Gravistat and the occurrence of squamous epithelial or adenomatous cervical neoplasias."
5.	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 08/01/1985 - " Therefore, Ovidan and Non-ovlon, containing 50 ug of estrogen, can only be used by healthy women under 35 years of age who have no lipid metabolism disorders. "

1.	Ethinyl Estradiol-Norgestrel Combination (Ovral)
2.	Contraceptive Agents (Contraceptives)
3.	Ovosiston (AK 103)
4.	Estrogens (Estrogen)
5.	Oral Contraceptives
6.	Progestins (Progestagens)